Your browser doesn't support javascript.
loading
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Lee, J-L; Kang, Y-K; Kang, H J; Lee, K-H; Zang, D Y; Ryoo, B-Y; Kim, J G; Park, S R; Kang, W K; Shin, D B; Ryu, M-H; Chang, H M; Kim, T-W; Baek, J H; Min, Y J.
Affiliation
  • Lee JL; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Korea.
Br J Cancer ; 99(4): 584-90, 2008 Aug 19.
Article in En | MEDLINE | ID: mdl-18665164

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Stomach Neoplasms / Tegafur / Deoxycytidine / Fluorouracil / Neoplasm Recurrence, Local / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Br J Cancer Year: 2008 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Stomach Neoplasms / Tegafur / Deoxycytidine / Fluorouracil / Neoplasm Recurrence, Local / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Br J Cancer Year: 2008 Type: Article